Third Point Takes Stake in Buffett-Backed Snowflake (Reuters)
(Reuters) – Billionaire investor and hedge fund owner Daniel Loeb told clients that one of his portfolios nursed small losses last month but was helped by positions in Snowflake Inc (SNOW) and Pinterest Inc (PINS), two fast-growing technology companies. The Third Point Offshore Fund is now up 3.6% for the year after slipping 0.7% in September following a gain of 8.4% in August.
Apple Inc (AAPL) COO Jeffrey E Williams Sold $29.2 million of Shares (Guru Focus)
COO of Apple Inc., Jeffrey E Williams, sold 257,343 shares of AAPL on 10/02/2020 at an average price of $113.59 a share. The total sale was $29.2 million. Apple Inc is designs, manufactures and markets mobile communication and media devices and personal computers, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications.
The Chairman of NervGen Pharma (Other OTC: NGENF) is Selling Shares (Analyst Ratings)
Today, the Chairman of NervGen Pharma (NGENF), William Joseph Radvak, sold shares of NGENF for $585K. Currently, NervGen Pharma has an average volume of 49.23K. The Company has a Price to Book ratio of 10.69. The insider sentiment on NervGen Pharma has been positive according to 10 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Pfizer Named Top Dividend Stock With Insider Buying And 4.18% Yield (Forbes)
In this series, we look through the most recent Dividend Channel ”DividendRank” report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider’s view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money – maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So when stocks turn up that see insider buying, and are also top dividends, investors are wise to take notice. One such company is Pfizer, which saw buying by Director Ronald E. Blaylock.
Catalent Inc (CTLT) Chair & CEO John R Chiminski Sold $15.7 million of Shares (Guru Focus)
Chair & CEO of Catalent Inc., John R Chiminski, sold 182,231 shares of CTLT on 10/02/2020 at an average price of $86.01 a share. The total sale was $15.7 million. Catalent Inc is a drug development, delivery and supply partner company. It engages in advanced delivery technologies and development solutions for drugs, biologics, and consumer health products across US, Europe and other international markets.
